The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

计划入组 49 人 · 首次发布于 2009 年 10 月 7 日

Tdose Binding and Tocilizumab

计划入组 122 人 · 首次发布于 2026 年 5 月 12 日

Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)

计划入组 730 人 · 首次发布于 2020 年 11 月 25 日

TDO inhibitor (NTRC)

TDO checkpoint inhibitor (IOmet Pharma)

TDO/IDO inhibitors (NewLink/Genentech)

TD GLOBAL HEALTHCARE LDRS INDX ETF UNIT

United States

RDO Pharm.

Mundipharma EDO GmbH

Switzerland

PROTAC Technology Emerges as Next-Generation Approach for IDO1-Targeted Cancer Immunotherapy

Tonix Pharmaceuticals' Tonmya™ Receives Conditional FDA Acceptance for Fibromyalgia Treatment

BD President Dr. Michael Garrison to Retire After Two Decades; BioPharma Systems to Report Directly to CEO